CIME 2025: Luke Lindsell, OD, MD, on bridging innovation and practical care in retinal disease

Published on May 8, 2025
Lindsell discusses promising retinal therapeutics, such as at-home therapies, gene therapy, and devices like the Valeda light delivery system (LumiThera), which uses photobiomodulation and shows early promise in preventing geographic atrophy altogether.
Continue reading on website
Other news

Oral zervimesine reduced GA lesion growth in phase 2 study from Cognition Therapeutics

May 8, 2025
Topline results from the Magnify phase 2 clinical trial of oral zervimesine show 28.6% slower geographic atrophy lesion growth compared with placebo.

Estrogen May Protect Against Optic Nerve Neurodegeneration

May 9, 2025
This study observed a dose-dependent relationship between age at menopause and RNFL thickness among women. Female patients who entered menopause before age 45 had an RNFL thickness of 121.0µm compared with 122.5µm in those who experienced menopause after age 50. Photo: Jarett Mazzarella, OD, and Justin Cole, OD. Click image to enlarge.  Recent research has explored the poten